Abstract
The risk of cancer from antihypertensive drugs has been much debated, with a recent analysis showing increased risk with angiotensin-receptor blockers (ARBs). We assessed the association between antihypertensive drugs and cancer risk in a comprehensive analysis of data from randomised clinical trials.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Lancet Oncology |
| Vol/bind | 12 |
| Udgave nummer | 1 |
| Sider (fra-til) | 65-82 |
| Antal sider | 18 |
| ISSN | 1470-2045 |
| DOI | |
| Status | Udgivet - 2011 |
| Udgivet eksternt | Ja |
Fingeraftryk
Dyk ned i forskningsemnerne om 'Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials'. Sammen danner de et unikt fingeraftryk.Citationsformater
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver